Implementation Survey of PrEP and Opioid Use Related Services In STI Clinics and MSM-Centered Community Based Organizations (CBOs)

Susan Tross, PhD
Co-Lead Investigator
Columbia University

Mary Hatch-Maillette, PhD
Co-Lead Investigator

University of Washington

While HIV incidence in the broader population in the US decreased by 18%, between 2008 and 2014, among men who have sex with men (MSM), it increased by 6%. Pre-exposure prophylaxis (PrEP) is at the cutting edge of HIV prevention worldwide, yet widespread use and promotion of PrEP has not been widely adopted. Also, despite of current evidence on efficacy of Naloxone and MAT interventions to prevent opioid overdose and treat opioid use disorders (OUD), appropriate models to implement in MSM-Centered CBOs are yet to be identified. Information (e.g. access, readiness, capacity, barriers, resource gaps, etc.) is needed to assist in the effort to increase awareness and use of PrEP and adoption of OUD interventions.

The study aims to identify health department STI clinics and and/or HIV-centered community-based organizations delivering services to assess: 1) program directors' and providers' knowledge/awareness of, interest in, perceived challenges/facilitators to and strategies for, offering PrEP and OUD interventions 2) and MSM's knowledge/awareness of, interest in, perceived challenges/facilitators to and recommended strategies for, being offered PrEP and OUD interventions.



Publications about CTN-0082

NIDA protocol page

Pacific Northwest (Co-Lead) search www
Greater New York (Co-Lead) search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2018 --